NEW YORK, June 10, 2019 /PRNewswire/ -- The BRIC diagnostic imaging equipment market is projected to grow at a CAGR of 9.2% during the forecast period. Read the full ...
Back in 2000, the FDA approved only six biologics versus 27 new molecular entities (NMEs). Fast-forward twenty plus years, and by the end of 2022 the number of approvals for biologics and advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results